| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |